Clearside Biomedical Inc logo

CLSD

Clearside Biomedical Inc

$0.86

Earnings Summary

Revenue
$1.02Mn
Net Profits
$-9.11Mn
Net Profit Margins
-894.5%

Highlights

Revenue:

Clearside Biomedical Inc’s revenue jumped 165.1% since last year same period to $1.02Mn in the Q2 2023. On a quarterly growth basis, Clearside Biomedical Inc has generated 25350% jump in its revenue since last 3-months.

Net Profits:

Clearside Biomedical Inc’s net profit fell -16.55% since last year same period to $-9.11Mn in the Q2 2023. On a quarterly growth basis, Clearside Biomedical Inc has generated 1.88% jump in its net profits since last 3-months.

Net Profit Margins:

Clearside Biomedical Inc’s net profit margin jumped 56.04% since last year same period to -894.5% in the Q2 2023. On a quarterly growth basis, Clearside Biomedical Inc has generated 99.61% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Clearside Biomedical Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.13
EPS Estimate Current Year
-0.13

Highlights

EPS Estimate Current Quarter:

Clearside Biomedical Inc’s earning per share (EPS) estimates for the current quarter stand at -0.13 - a -333.33% fall from last quarter’s estimates.

EPS Estimate Current Year:

Clearside Biomedical Inc’s earning per share (EPS) estimates for the current year stand at -0.13.

Key Ratios

Key ratios of the Clearside Biomedical Inc post its Q1 2023 earnings

Return on Assets (ROA)
-0.53
Return on Equity (ROE)
-3.54

Highlights

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Clearside Biomedical Inc’s return on assets (ROA) stands at -0.53.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Clearside Biomedical Inc’s return on equity (ROE) stands at -3.54.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-12
-0.08
-0.13
-62.5%
2022-11-09
-0.03
-0.13
-333.33%
2022-08-12
-0.13
-0.13
0%